, Singapore

High cost of dialysis slows APAC's kidney disease market

The market is dominated by the diagnosis segment.

The high cost of dialysis treatment in Asia-Pacific is slowing the growth of the kidney disease market in the region, which is tipped to reach $37.20b in 2027 from $21.9b in 2019, according to a report from Research and Markets.

The market is estimated to grow with a compound annual growth rate (CAGR) of 6.9% from 2020-2027, amidst a rising incidence of end-stage diseases and high development in government expenditure in the healthcare industry.

The diagnosis segment held the largest share of the market in 2019, and is anticipated to register the highest CAGR in the market during the period.

Chronic kidney disease can be diagnosed with blood and urine tests. The tests must be performed in conditions such as diabetes, high blood pressure, heart disease, and a family history of kidney failure.
 

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Saudi’s KFSHRC banks on innovation to transform healthcare
The hospital is accelerating adoption of emerging technologies to position itself as a global leader in medicine
Angkor Hospital eyes trauma centre for children
The facility will have an ICU, emergency room, operating theatre and a surgical ward.